Arrowhead raises $216.6 million net proceeds via common stock and pre-funded warrants offering
What happened
5 signals in this filing. On January 7, 2026, the Company entered into an underwriting agreement with Jefferies and J.P. Morgan for an offering of common stock and pre-funded warrants that closed January 9, 2026, raising $230.0 million in...
Source
Extracted by Autobound
From the Signal API record- Signal
- SEC 10-K
What this signalsFilings often name leadership changes, deals and spending plans.
- Filed
- Nov 12, 2026
More SEC 10-K signals at other companies
- SEC 10-KEdgewell Personal Care CompanyClosed sale of Feminine Care business to Essity for approximately $340 millionSEC 10-K
- SEC 10-KFranklin Covey Co.Franklin Covey explicitly lists competitors across Enterprise and Education divisions in 10-KSEC 10-K
- SEC 10-KTennessee Valley Authority Parrs A 2029Revenues from LPCs Accounted for Approximately 90 Percent of TVA's Operating Revenues in 2026SEC 10-K
The full record
From the Signal API recordNumbers
- Dollar figuregross proceeds from offering of common stock and pre-funded warrants
- $230M
Details
- CIK
- 879407
- Accession number
- 0000879407-26-000078
- Timeframe
- Current year
- Filing year
- 2026
- Fiscal year end
- 09/30
- Why it matters
- New capital available
- Signal category
- Financial
Topics and mentions
Vendors named
- Jefferies
- J.P. Morgan
Extraction
- Confidence
- High
- Relevance
- 85%
- Sentiment
- Positive
- Detected
- Nov 17, 2026
- signal_type
sec-10k- signal_subtype
equityRaise
Use this data
Get every SEC 10-K signal for Arrowhead Pharmaceuticals, Inc. and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Arrowhead Pharmaceuticals, Inc. this week?”
Send it to your own tools
The Signal API returns SEC 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/fad50495-5238-414b-bf38-91f1fb2cba59 returns this record as JSON. POST /v1/companies/enrich returns every signal for arrowheadpharma.com.
{
"signal_id": "fad50495-5238-414b-bf38-91f1fb2cba59",
"signal_type": "sec-10k",
"signal_subtype": "equityRaise",
"detected_at": "2026-11-17T07:03:12.715+00:00",
"company": {
"name": "Arrowhead Pharmaceuticals, Inc.",
"domain": "arrowheadpharma.com"
},
"data": {
"detail": "On January 7, 2026, the Company entered into an underwriting agreement with Jefferies and J.P. Morgan for an offering of common stock and pre-funded warrants that closed January 9, 2026, raising $230.0 million in gross proceeds and $216.6 million net proceeds. For sellers: Expanded capital reserves may facilitate further investments in clinical and commercial development.",
"metrics": {
"timeframe": "current_year",
"dollar_context": "gross proceeds from offering of common stock and pre-funded warrants",
"dollar_millions": 230
},
"summary": "Arrowhead raises $216.6 million net proceeds via common stock and pre-funded warrants offering",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000078/arwr-20260930.htm",
"filing_date": "2026-11-12",
"filing_year": 2026,
"fiscal_year_end": "09/30",
"sales_relevance": "New capital available",
"signal_category": "financial",
"vendors_mentioned": [
"Jefferies",
"J.P. Morgan"
]
}
}
curl https://signals.autobound.ai/v1/signals/fad50495-5238-414b-bf38-91f1fb2cba59 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"arrowheadpharma.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.